Clostridioides difficile spores and surface layer proteins (C. diff spores/SLPs)

Clostridioides difficile spores and surface layer proteins (SLPs) are fundamental to the lifecycle and virulence of the pathogen responsible for severe healthcare-associated diarrhea. Spores are metabolically inactive, highly resilient structures that allow the bacteria to survive antibiotic treatment and environmental disinfectants, serving as the primary vehicle for transmission (Kirk et al., 2017, PMID: 28260786). Once ingested, these spores germinate in the anaerobic environment of the colon, where the resulting vegetative cells express a paracrystalline surface layer composed mainly of the SlpA protein. This S-layer is crucial for the bacteria's ability to adhere to the host's intestinal epithelium and evade the innate immune system by masking underlying motifs (Fagan and Fairweather, 2014, PMID: 25151268). Therapeutic interventions targeting these components, such as anti-SlpA antibodies or germination inhibitors, aim to break the cycle of infection and recurrence that characterizes CDI. For instance, the antibiotic fidaxomicin has been shown to inhibit sporulation, thereby reducing environmental shedding and the risk of relapse (Allen et al., 2013, PMID: 23460511). By focusing on the structural and survival mechanisms of the bacteria rather than just its toxins, these approaches offer a strategy to reduce the persistence of C. difficile in the gut and the environment. However, the high degree of sequence variation in SLPs across different ribotypes remains a significant challenge for the development of universal vaccines or monoclonal antibodies (Péchiné et al., 2013, PMID: 23533544).

Other names

C. difficile S-layerSlpASpore coat proteinsC. diff surface proteinsSurface layer protein ACdeCCotA

Inhibition of bacterial adhesion to the intestinal mucosa, prevention of dormant spore germination into toxin-producing vegetative cells, and reduction of environmental persistence through the inhibition of sporulation pathways.